FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Jul 7, 2026
0
7
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: News and Research on Graves Ophthalmopathy
MeSH tree: C16.320.290.410
Thyroid eye disease tied to higher prevalence of human papillomavirus
Patients with thyroid eye disease (TED) have a higher prevalence of low-risk human papillomavirus (HPV) diagnosed before autoimmune hyperthyroidism onset than matched controls, according to a research letter published online ...
Feb 25, 2026
0
7
Researchers find link between HPV and thyroid eye disease
University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus (HPV) to thyroid eye disease (TED) through molecular mimicry involving HPV capsid proteins and autoimmune ...
Understanding Graves' disease
Graves' disease is a condition of the immune system that leads to an overactive thyroid. It is caused by antibodies attacking the thyroid by mistake. The thyroid and the hormones it produces are the gas pedal for the body. ...
Sep 4, 2024
0
23
Thyroid eye disease patients report maintained improvement two years after teprotumumab infusions
Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatment nearly two years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's ...
Jun 2, 2024
0
37
US regulator, Amgen reach deal to unblock biopharma acquisition
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
61
US sues to block $28 bn Amgen biopharma acquisition
US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.
May 16, 2023
0
49
US biopharma firm Amgen to acquire Horizon Therapeutics for $28 bn
US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.
Dec 12, 2022
0
49
Consensus statement on management of thyroid eye disease
The American Thyroid Association (ATA) and European Thyroid Association (ETA) have collaborated on the "Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and European Thyroid Association." ...
Dec 9, 2022
0
76
